-
Je něco špatně v tomto záznamu ?
Design, Synthesis and Evaluation of Novel Phthalimide Derivatives as in Vitro Anti-Microbial, Anti-Oxidant and Anti-Inflammatory Agents
PF. Lamie, JN. Phillopes, AO. El-Gendy, L. Rarova, J. Gruz,
Jazyk angličtina Země Švýcarsko
Typ dokumentu hodnotící studie, časopisecké články
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- antiflogistika chemická syntéza farmakologie MeSH
- antiinfekční látky chemická syntéza farmakologie MeSH
- antioxidancia chemická syntéza farmakologie MeSH
- Bacteria účinky léků MeSH
- endoteliální buňky pupečníkové žíly (lidské) účinky léků metabolismus MeSH
- ftalimidy chemická syntéza farmakologie MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- molekulární modely MeSH
- nádorové buňky kultivované MeSH
- nádory farmakoterapie patologie MeSH
- NF-kappa B metabolismus MeSH
- proliferace buněk účinky léků MeSH
- racionální návrh léčiv * MeSH
- reaktivní formy kyslíku metabolismus MeSH
- techniky in vitro MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
Sixteen new phthalimide derivatives were synthesized and evaluated for their in vitro anti-microbial, anti-oxidant and anti-inflammatory activities. The cytotoxicity for all synthesized compounds was also determined in cancer cell lines and in normal human cells. None of the target derivatives had any cytotoxic activity. (ZE)-2-[4-(1-Hydrazono-ethyl) phenyl]isoindoline-1,3-dione (12) showed remarkable anti-microbial activity. Its activity against Bacillus subtilis was 133%, 106% and 88.8% when compared with the standard antibiotics ampicillin, cefotaxime and gentamicin, respectively. Compound 12 also showed its highest activities in Gram negative bacteria against Pseudomonas aeruginosa where the percentage activities were 75% and 57.6% when compared sequentially with the standard antibiotics cefotaxime and gentamicin. It was also found that the compounds 2-[4-(4-ethyl-3-methyl-5-thioxo-1,2,4-triazolidin-3-yl)phenyl]isoindoline-1,3-dione (13b) and 2-[4-(3-methyl-5-thioxo-4-phenyl-1,2,4-triazolidin-3-yl)phenyl]isoindoline-1,3-dione (13c) had anti-oxidant activity. 4-(N'-{1-[4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-phenyl]-ethylidene}-hydrazino)-benzenesulfonamide (17c) showed the highest in vitro anti-inflammatory activity of the tested compounds (a decrease of 32%). To determine the mechanism of the anti-inflammatory activity of 17c, a docking study was carried out on the COX-2 enzyme. The results confirmed that 17c had a higher binding energy score (-17.89 kcal/mol) than that of the ligand celecoxib (-17.27 kcal/mol).
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17001005
- 003
- CZ-PrNML
- 005
- 20170119121028.0
- 007
- ta
- 008
- 170103s2015 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules200916620 $2 doi
- 024 7_
- $a 10.3390/molecules200916620 $2 doi
- 035 __
- $a (PubMed)26389864
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Lamie, Phoebe F $u Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni Suef University, Beni Suef 62514, Egypt. feby.farag@yahoo.com.
- 245 10
- $a Design, Synthesis and Evaluation of Novel Phthalimide Derivatives as in Vitro Anti-Microbial, Anti-Oxidant and Anti-Inflammatory Agents / $c PF. Lamie, JN. Phillopes, AO. El-Gendy, L. Rarova, J. Gruz,
- 520 9_
- $a Sixteen new phthalimide derivatives were synthesized and evaluated for their in vitro anti-microbial, anti-oxidant and anti-inflammatory activities. The cytotoxicity for all synthesized compounds was also determined in cancer cell lines and in normal human cells. None of the target derivatives had any cytotoxic activity. (ZE)-2-[4-(1-Hydrazono-ethyl) phenyl]isoindoline-1,3-dione (12) showed remarkable anti-microbial activity. Its activity against Bacillus subtilis was 133%, 106% and 88.8% when compared with the standard antibiotics ampicillin, cefotaxime and gentamicin, respectively. Compound 12 also showed its highest activities in Gram negative bacteria against Pseudomonas aeruginosa where the percentage activities were 75% and 57.6% when compared sequentially with the standard antibiotics cefotaxime and gentamicin. It was also found that the compounds 2-[4-(4-ethyl-3-methyl-5-thioxo-1,2,4-triazolidin-3-yl)phenyl]isoindoline-1,3-dione (13b) and 2-[4-(3-methyl-5-thioxo-4-phenyl-1,2,4-triazolidin-3-yl)phenyl]isoindoline-1,3-dione (13c) had anti-oxidant activity. 4-(N'-{1-[4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-phenyl]-ethylidene}-hydrazino)-benzenesulfonamide (17c) showed the highest in vitro anti-inflammatory activity of the tested compounds (a decrease of 32%). To determine the mechanism of the anti-inflammatory activity of 17c, a docking study was carried out on the COX-2 enzyme. The results confirmed that 17c had a higher binding energy score (-17.89 kcal/mol) than that of the ligand celecoxib (-17.27 kcal/mol).
- 650 _2
- $a antiinfekční látky $x chemická syntéza $x farmakologie $7 D000890
- 650 _2
- $a antiflogistika $x chemická syntéza $x farmakologie $7 D000893
- 650 _2
- $a antioxidancia $x chemická syntéza $x farmakologie $7 D000975
- 650 _2
- $a Bacteria $x účinky léků $7 D001419
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 12
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a endoteliální buňky pupečníkové žíly (lidské) $x účinky léků $x metabolismus $7 D061307
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a NF-kappa B $x metabolismus $7 D016328
- 650 _2
- $a nádory $x farmakoterapie $x patologie $7 D009369
- 650 _2
- $a ftalimidy $x chemická syntéza $x farmakologie $7 D010797
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Phillopes, John N $u Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni Suef University, Beni Suef 62514, Egypt. john_philoppes@yahoo.com.
- 700 1_
- $a El-Gendy, Ahmed O $u Department of Microbiology & Immunology, Faculty of Pharmacy, Beni Suef University, Beni Suef 62514, Egypt. dr.ahmed_micro@yahoo.com.
- 700 1_
- $a Rarova, Lucie $u Laboratory of Growth Regulators & Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Institute of Experimental Botany ASCR & Palacký University, Šlechtitelů 27, 783 71 Olomouc, The Czech Republic. lucie.rarova@upol.cz.
- 700 1_
- $a Gruz, Jiri $u Laboratory of Growth Regulators & Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Institute of Experimental Botany ASCR & Palacký University, Šlechtitelů 27, 783 71 Olomouc, The Czech Republic. jiri.gruz@upol.cz.
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 20, č. 9 (2015), s. 16620-42
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26389864 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170119121137 $b ABA008
- 999 __
- $a ok $b bmc $g 1180145 $s 961572
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 20 $c 9 $d 16620-42 $e 20150914 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20170103